Metallocyclodextrins in medicinal chemistry

Future Med Chem. 2018 Mar 1;10(6):663-677. doi: 10.4155/fmc-2017-0249. Epub 2018 Feb 8.

Abstract

This review focuses on metal complexes of cyclodextrin (CyD) derivatives designed for application as therapeutics or diagnostics. We discuss examples of metalloprotein models (hemoglobin, superoxide dismutase and catalase) based on cyclodextrins. The hydrophobic microenvironment of CyDs stabilizes the Fe(II) porphyrin system that can reversibly bind O2 or CO in water. Superoxide dismutase/catalase mimetics exploit functionalization with CyDs, which increase their solubility and biological activity. Furthermore, CyDs have been used as scaffolds to obtain multicenter metal complexes: paramagnetic systems act as high-performance contrast agents for magnetic resonance imaging applications. Finally, we review CyD ligands, whose use appears promising in metal chelation therapy, as CyD moiety confers additional properties to the ligands.

Keywords: bioinorganic chemistry; drug delivery; metal complexes.

Publication types

  • Review

MeSH terms

  • Animals
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / pharmacology
  • Chemistry, Pharmaceutical*
  • Coordination Complexes / chemistry*
  • Coordination Complexes / metabolism
  • Dextrans / chemistry*
  • Drug Carriers / chemistry*
  • Humans
  • Oxidative Stress / drug effects
  • Oxidoreductases / chemistry
  • Oxidoreductases / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Biocompatible Materials
  • Coordination Complexes
  • Dextrans
  • Drug Carriers
  • Reactive Oxygen Species
  • Oxidoreductases